Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
Forte Biosciences Price : 76.99 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 10, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 09, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 08, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 04, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 03, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 02, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 01, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Aug 31, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Aug 28, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Aug 27, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Aug 26, 2026 | 76.97 | 77.00 | 76.96 | 76.99 | 1.400M |
| Aug 25, 2026 | 76.96 | 76.98 | 76.95 | 76.97 | 1.236M |
| Aug 24, 2026 | 76.94 | 76.95 | 76.92 | 76.95 | 1.256M |
| Aug 21, 2026 | 76.94 | 76.95 | 76.89 | 76.92 | 2.012M |
| Aug 20, 2026 | 76.93 | 76.95 | 76.82 | 76.89 | 3.196M |
| Aug 19, 2026 | 76.89 | 76.94 | 76.87 | 76.90 | 6.480M |
| Aug 18, 2026 | 76.86 | 76.91 | 76.85 | 76.88 | 771130.0 |
| Aug 17, 2026 | 76.85 | 76.90 | 76.84 | 76.89 | 558159.0 |
| Aug 14, 2026 | 76.86 | 76.87 | 76.82 | 76.83 | 490256.0 |
| Aug 13, 2026 | 76.82 | 76.88 | 76.78 | 76.86 | 1.151M |
| Aug 12, 2026 | 76.87 | 76.90 | 76.76 | 76.78 | 1.924M |
| Aug 11, 2026 | 76.84 | 76.89 | 76.81 | 76.87 | 1.053M |
| Aug 10, 2026 | 76.82 | 76.83 | 76.78 | 76.82 | 765247.0 |
| Aug 07, 2026 | 76.82 | 76.85 | 76.76 | 76.79 | 1.164M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| argenx SE | 984.39 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Anika Therapeutics, Inc. | 20.86 |
| Savara, Inc. | 5.30 |
Price Related Metrics
| Price to Book Value | 8.580 |
| Earnings Yield | -6.66% |
| Market Cap | 1.577B |